ENZN

DellaCamera Sends Letter to Enzon Board of Directors - 10/06 - 10:15 AM ET

Enzon granted orphan drug status for new cancer drug in EU - 10/01 - 10:17 AM ET

ENZN: Receives Orphan Drug Status in EU for Oncaspar-IV(TM) - 09/30 - 08:39 AM ET

Enzon's New Oncaspar-IV(TM) Receives Orphan Drug Status in The EU - 09/30 - 08:30 AM ET

Enzon Pharmaceuticals Inc explores strategic alternatives for specialty pharmaceuticals business - 08/12 - 04:18 AM ET

Enzon Pharmaceuticals Climbs On Increased Volume During Pre-Market - 08/11 - 09:00 AM ET

ENZON PHARMA EXPLORING ALTERNATIVES FOR SPECIALTY PHARMA BUSINESS - 08/11 - 08:31 AM ET

Enzon Pharmaceuticals Announces Intention to Explore Strategic Alternatives for Specialty Pharmaceuticals Business - 08/11 - 08:27 AM ET

ENZN: To Present At BMO Focus on Healthcare Conference @ 11:45 ET [delayed] - 08/06 - 10:24 AM ET

ENZN: Q2 Earnings Call @ 09:00 ET Today [delayed] - 08/06 - 07:32 AM ET

Enzon Files for Spin-off of Biotech Business - 07/31 - 06:05 AM ET

Enzon to Release Second Quarter 2008 Earnings on Wednesday, August 6, 2008; Conference Call and Webcast to Follow - 07/29 - 08:00 AM ET

ENZN: Eliminates Remaining 2008 Debt - 07/02 - 08:54 AM ET

Enzon Pharmaceuticals Drops Below Trading Range, Hits 2-Month Low - 06/03 - 02:38 PM ET

The Street Corner: Enzon Stockholders Approve Company Proposals at 2008 Annual Meeting - 05/23 - 04:50 AM ET

Enzon Stockholders Approve Company Proposals at 2008 Annual Meeting - 05/22 - 09:55 AM ET

Streetinvesting.com: Enzon Announces Clinical Data from PEG-SN38 and rhMBL Studies at ASCO - 05/20 - 01:17 PM ET

Shareholder Demands Enzon Explore All Strategic Alternatives for Commercial Operations - 05/20 - 12:24 PM ET

ENZN: New Clinical Data from Ph I Trial of PEG-SN38 - 05/20 - 09:12 AM ET

Enzon Announces Clinical Data from PEG-SN38 and rhMBL Studies at ASCO - 05/20 - 08:20 AM ET

Page 1 of 4     1  2   3   4      Previous  |  Next

<< Back to Stock Index